SCHEMBL19903610

SCHEMBL19903610

N#Cc1ccc(-c2ccc3c4ccc(-c5ccc(C#N)cc5C#N)cc4n(-c4cc(-c5cc(C(F)(F)F)cc(C(F)(F)F)c5)c(-n5c6cc(-c7ccc(C#N)cc7C#N)ccc6c6ccc(-c7ccc(C#N)cc7C#N)cc65)cc4C#N)c3c2)c(C#N)c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
KIF11 P52732 1/20 0.35
STS P08842 1/20 0.34
XDH P47989 2/20 0.34
RXRA P19793 1/20 0.33
RXRG P48443 1/20 0.33
PDPK1 O15530 1/20 0.31
TMPRSS4 Q9NRS4 1/20 0.30
DGAT1 O75907 1/20 0.30
SOAT1 P35610 1/20 0.30
KCNH2 Q12809 1/20 0.30
KDM1A O60341 1/20 0.30
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30
CYP11B1 P15538 1/20 0.30
CYP11B2 P19099 1/20 0.30
AR P10275 1/20 0.30
CETP P11597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20617398 0.97 RXRA (0.36) ALOX5APFEN1KIF11STSXDH
SCHEMBL19903601 0.96 XDH (0.34) ALOX5APFEN1KIF11STSXDH
SCHEMBL20617406 0.93 RXRA (0.34) ALOX5APFEN1KIF11STSXDH
SCHEMBL19903609 0.92 ALOX5AP (0.35) ALOX5APFEN1KIF11STSXDH
SCHEMBL19903626 0.91 KIF11 (0.36) KIF11XDHRXRARXRGPDPK1
SCHEMBL19918005 0.91 STS (0.34) ALOX5APFEN1KIF11STSXDH
SCHEMBL20617113 0.91 RXRA (0.38) ALOX5APFEN1KIF11STSXDH
SCHEMBL19903593 0.90 KIF11 (0.43) KIF11RXRARXRGPDPK1DGAT1
SCHEMBL19903595 0.90 XDH (0.34) ALOX5APFEN1KIF11STSXDH
SCHEMBL20925049 0.90 ALOX5AP (0.34) ALOX5APFEN1KIF11STSXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 ALOX5AP 3371/4885FEN1 1443/4885KIF11 3253/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 ALOX5AP 3376/4885FEN1 1603/4885KIF11 3316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.